Ligand ID: X6X Drugbank ID: DB01296(Glucosamine) Indication:Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | 18.82 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 29GLY A 146VAL A 42HIS A 164 | 1.79A | 18.82 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.52A | 18.82 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | 17.00 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | 17.00 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.44A | 16.94 | N0A D 2 ( 4.0A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.57A | 16.94 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.56A | 16.94 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY C 146VAL C 114HIS C 163HIS C 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.45A | 16.83 | 3WL A 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS B 41VAL B 42ASP B 187HIS B 164 | 1.69A | 16.83 | 3WL B 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.43A | 16.83 | 3WL A 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY B 146VAL B 114HIS B 163HIS B 164 | 1.57A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY C 146VAL C 114HIS C 163HIS C 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY B 146VAL B 114HIS B 163HIS B 164 | 1.57A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.56A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.55A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.58A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 485GLY A 486HIS A 572HIS A 642 | 1.46A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.32A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.58A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 572GLY A 485GLY A 486HIS A 642 | 1.42A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 572GLY A 485GLY A 486HIS A 642 | 1.40A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.57A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 485GLY A 486HIS A 572HIS A 642 | 1.41A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.51A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.44A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.44A | NoneNHE B 203 (-4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.51A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.43A | NoneNHE B 203 (-4.9A)NoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.49A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.49A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 8 | HIS B 59GLY B 60ASP C 82HIS C 145 | 1.30A | 23.03 | ZN C 201 ( 3.1A)None ZN C 201 ( 2.1A) ZN C 201 ( 3.2A) | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w4h | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.14A | 16.89 | SAM A7102 (-3.4A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.20A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.13A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.56A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneNoneNoneAMP A 201 ( 3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneNoneNoneAMP A 201 ( 3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.62A | 19.79 | SAM A7102 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.62A | 19.79 | SAM C7105 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.59A | 19.79 | SAM C7105 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | 19.79 | SAM A7102 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | 19.79 | SAM C7105 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.16A | 19.79 | SAM A7102 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.15A | 19.79 | SAM C7105 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.60A | 19.79 | SAM A7102 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU C 51HIS C 50VAL C 7HIS C 47 | 1.68A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU B 263HIS B 272GLY B 266GLY B 271 | 1.43A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU B 263HIS B 272GLY B 266GLY B 271 | 1.43A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU C 51HIS C 50VAL C 7HIS C 47 | 1.66A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.48A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.53A | NoneMES A 202 (-3.4A)MES A 202 (-4.7A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.53A | NoneMES A 202 (-3.4A)MES A 202 (-4.7A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.48A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.46A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 47GLY A 46VAL A 49HIS A 45 | 1.67A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 249GLY A 251GLY A 250VAL A 253 | 1.59A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 289VAL A 286HIS A 298HIS A 290 | 1.44A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 289VAL A 286HIS A 298HIS A 290 | 1.44A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 249GLY A 251GLY A 250VAL A 253 | 1.60A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.64A | SAH C7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAH A7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | SAH A7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SAH A7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.16A | SAH C7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | SAH C7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.61A | SAH C7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.17A | SAH A7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | HIS B 145GLY A 60HIS A 59ASP B 82 | 1.68A | ZN B 202 (-3.3A)None ZN B 202 (-2.6A) ZN B 202 (-2.3A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.62A | SFG C7103 ( 3.7A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SFG A7103 ( 3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.15A | SFG C7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | SFG C7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.17A | SFG A7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | SFG A7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SFG A7103 ( 3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.59A | SFG C7103 ( 3.7A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS A 250GLY A 239VAL A 295HIS A 235 | 1.41A | U5P A 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS B 250GLY B 239VAL B 295HIS B 235 | 1.38A | U5P B 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS A 250GLY A 239VAL A 295HIS A 235 | 1.43A | U5P A 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS B 250GLY B 239VAL B 295HIS B 235 | 1.40A | U5P B 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | U5G A 401 (-3.3A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.57A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.46A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.65A | NoneAPR A 201 (-4.1A)APR A 201 (-3.9A)APR A 201 (-3.8A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.69A | NoneAPR D 201 (-4.2A)APR D 201 (-3.8A)APR D 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.65A | NoneAPR C 201 (-4.1A)APR C 201 (-3.9A)APR C 201 (-3.8A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.63A | NoneAPR C 201 (-4.1A)APR C 201 (-3.9A)APR C 201 (-3.8A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 103VAL A 77ASP B 135HIS B 138 | 1.55A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 103VAL A 77ASP B 135HIS B 138 | 1.51A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.68A | NoneAPR B 201 (-4.0A)APR B 201 (-3.7A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.21A | SAH A7101 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SAH A7101 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.15A | SAH A7101 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAH A7101 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS B 41VAL B 42ASP B 187HIS B 164 | 1.34A | 16.83 | O6K B 401 ( 3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | 18.60 | NoneNoneDMS A 405 (-3.9A)None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 29GLY A 146VAL A 42HIS A 164 | 1.79A | 18.60 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | 18.60 | NoneNoneDMS A 405 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNoneP6N A 502 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | NoneNoneP6N A 502 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | NoneNoneDMS A 403 (-4.1A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | PK8 A 401 (-3.2A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNoneDMS A 403 (-4.1A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.51A | NoneEDO D 206 (-4.5A)EDO D 206 ( 4.6A)EDO D 209 (-4.6A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.50A | NoneEDO D 206 (-4.5A)EDO D 206 ( 4.6A)EDO D 209 (-4.6A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.49A | NoneEPE E 202 (-4.3A)EPE E 202 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.49A | NoneEPE E 202 (-4.3A)EPE E 202 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.66A | NoneAPR E 201 (-4.4A)APR E 201 (-3.9A)APR E 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneAPR A 201 (-4.1A)APR A 201 (-4.2A)APR A 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.55A | NoneAPR B 201 (-3.6A)EDO B 202 (-3.9A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.65A | NoneAPR D 201 ( 4.3A)APR D 201 (-3.8A)APR D 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.60A | NoneAPR C 201 (-4.3A)APR C 201 (-4.3A)APR C 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | NoneAPR B 201 (-3.6A)EDO B 202 (-3.9A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.62A | NoneAPR C 201 (-4.3A)APR C 201 (-4.3A)APR C 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.54A | NoneAPR A 201 (-4.1A)APR A 201 (-4.2A)APR A 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.49A | NoneMES A 201 ( 4.8A)MES A 201 ( 4.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.42A | NoneEDO B 203 ( 4.6A)NoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | NoneMES C 201 ( 4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | NoneMES C 201 ( 4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | NoneEDO B 203 ( 4.6A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | NoneMES A 201 ( 4.8A)MES A 201 ( 4.9A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.51A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.52A | NoneNonePJE C 5 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNonePJE C 5 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 683VAL A 662ASP A 623 | 1.43A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.65A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 559GLY A 503VAL A 667 | 1.32A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 683VAL A 662ASP A 623 | 1.48A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 559GLY A 503VAL A 667 | 1.35A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | NoneNoneDMS A 402 (-3.9A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | NoneNoneDMS A 402 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.66A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.37A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.38A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.64A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.63A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.37A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.60A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.57A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.35A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667ASP A 684 | 1.65A | None |